285 related articles for article (PubMed ID: 36230984)
21. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
22. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
23. The signal transducer and activator of transcription factors lodge in immunopathogenesis of rheumatoid arthritis.
Zare F; Dehghan-Manshadi M; Mirshafiey A
Reumatismo; 2015 Dec; 67(4):127-37. PubMed ID: 27215178
[TBL] [Abstract][Full Text] [Related]
24. The role of STATs in inflammation and inflammatory diseases.
Pfitzner E; Kliem S; Baus D; Litterst CM
Curr Pharm Des; 2004; 10(23):2839-50. PubMed ID: 15379672
[TBL] [Abstract][Full Text] [Related]
25. STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and
Hedl M; Sun R; Huang C; Abraham C
J Immunol; 2019 Dec; 203(12):3325-3338. PubMed ID: 31732533
[TBL] [Abstract][Full Text] [Related]
26. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma.
Ni Z; Lou W; Lee SO; Dhir R; DeMiguel F; Grandis JR; Gao AC
J Urol; 2002 Apr; 167(4):1859-62. PubMed ID: 11912448
[TBL] [Abstract][Full Text] [Related]
27. STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma.
Matsuzaki K; Fujita K; Hayashi Y; Matsushita M; Nojima S; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Uemura M; Imamura R; Yamaguchi S; Fushimi H; Miyamoto H; Morii E; Nonomura N
PLoS One; 2018; 13(8):e0201256. PubMed ID: 30091994
[TBL] [Abstract][Full Text] [Related]
28. Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.
Klupp F; Diers J; Kahlert C; Neumann L; Halama N; Franz C; Schmidt T; Lasitschka F; Warth A; Weitz J; Koch M; Schneider M; Ulrich A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1548-55. PubMed ID: 25773877
[TBL] [Abstract][Full Text] [Related]
29. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.
Nielsen M; Kaltoft K; Nordahl M; Röpke C; Geisler C; Mustelin T; Dobson P; Svejgaard A; Odum N
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6764-9. PubMed ID: 9192639
[TBL] [Abstract][Full Text] [Related]
30. Role of STAT3 in cancer metastasis and translational advances.
Kamran MZ; Patil P; Gude RP
Biomed Res Int; 2013; 2013():421821. PubMed ID: 24199193
[TBL] [Abstract][Full Text] [Related]
31. Stat transcription factors in mammary gland development and tumorigenesis.
Watson CJ
J Mammary Gland Biol Neoplasia; 2001 Jan; 6(1):115-27. PubMed ID: 11467447
[TBL] [Abstract][Full Text] [Related]
32. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.
Stancato LF; David M; Carter-Su C; Larner AC; Pratt WB
J Biol Chem; 1996 Feb; 271(8):4134-7. PubMed ID: 8626752
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression.
Varco-Merth B; Rotwein P
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E847-55. PubMed ID: 25205818
[TBL] [Abstract][Full Text] [Related]
34. Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature.
Mohan CD; Rangappa S; Preetham HD; Chandra Nayaka S; Gupta VK; Basappa S; Sethi G; Rangappa KS
Semin Cancer Biol; 2022 May; 80():157-182. PubMed ID: 32325172
[TBL] [Abstract][Full Text] [Related]
35. STAT proteins: from normal control of cellular events to tumorigenesis.
Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
[TBL] [Abstract][Full Text] [Related]
36. Analysis of STAT1, STAT2 and STAT3 mRNA expression levels in the blood of patients with multiple sclerosis.
Manoochehrabadi S; Arsang-Jang S; Mazdeh M; Inoko H; Sayad A; Taheri M
Hum Antibodies; 2019; 27(2):91-98. PubMed ID: 30412483
[TBL] [Abstract][Full Text] [Related]
37. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
38. Expression of activated and latent signal transducer and activator of transcription 3 in 303 non-small cell lung carcinomas and 44 malignant mesotheliomas: possible role for chemotherapeutic intervention.
Achcar Rde O; Cagle PT; Jagirdar J
Arch Pathol Lab Med; 2007 Sep; 131(9):1350-60. PubMed ID: 17824789
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
[TBL] [Abstract][Full Text] [Related]
40. Targeting signal transducer and activator of transcription signaling pathway in leukemias.
Benekli M; Baumann H; Wetzler M
J Clin Oncol; 2009 Sep; 27(26):4422-32. PubMed ID: 19667270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
